Perspective Therapeutics Inc (CATX): Dawson initiates coverage. With a $1....

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	15
Posts	571
Boards Moderated	1
Alias Born	08/04/2011

Roland Rick Perry

Re: None

Wednesday, 07/17/2019 12:03:35 PM

Wednesday, July 17, 2019 12:03:35 PM

Dawson initiates coverage.

With a $1.00 PT

https://www.biotuesdays.com/briefs/2019/7/2/dawson-james-starts-isoray-at-buy-pt-1

I haven't looked at this in ten years!

Seems like they're still treading water (sales-wise).

Have to check out this new Blu thing. While I smoking a Blu!

Sales and marketing expenses were $645,000 to generate $1.9 million in sales. Maybe they're investing for the future..

"This fiscal third quarter of 2019 marks our eighth consecutive quarter of double-digit revenue growth with sales growing 22% over the year-ago quarter. Once again, the key driver of growth this quarter was IsoRay’s core prostate brachytherapy revenue which increased 30% versus the fiscal third quarter of 2018."

"We continue to estimate that Blu Build expands our domestic prostate cancer opportunity by $25 million to approximately $100 million."

https://seekingalpha.com/article/4262241-isoray-inc-isr-ceo-lori-woods-q3-2019-results-earnings-call-transcript?part=single